Preliminary outcomes of a prospective observational study of combinatorial abiraterone acetate/enzalutamide (AA/Enz) and radical radiotherapy (RT) in nonmetastatic node-positive (N+M0) prostate cancer (PCa).

Mark Ting Le Tan,Wai Yee Woo,Jeffrey Kit Loong Tuan,Terence Wee Kiat Tan,Michael Lian Chek Wang,Eu Tiong Chua,Wen Shen Looi,Youquan Li,Wen Long Nei,Haitao Wang,Anusha Chimmiri,Adelene Sim Yen Ling,Enya Hui Wen Ong,Li Yan Khor,Joe Poh Sheng Yeong,Chien Sheng Tan,Kae Jack Tay,Lui Shiong Lee,Ravindran Kanesvaran,Melvin L.K. Chua

Preliminary outcomes of a prospective observational study of combinatorial abiraterone acetate/enzalutamide (AA/Enz) and radical radiotherapy (RT) in nonmetastatic node-positive (N+M0) prostate cancer (PCa).

2020

227Background: Treatment paradigm for N+M0 PCa has evolved, with the advent of multiple options for upfront AA/Enz or RT in combination with conventional hormonal therapy (HT). However, the optimal...

Keywords:

Observational study
Oncology
Prostate cancer
Abiraterone acetate
Radiation therapy
Pathology
Internal medicine
Enzalutamide
Medicine
Hormonal therapy
radical radiotherapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations